Mets second baseman Robinson Cano will be stopped in 162 games (the length of the regular MLB season) after a positive performance-enhancing drug test, Major League Baseball announced Wednesday.
According to MLB, Kano tested positive for stanozolol.
He will lose $ 24 million in salary for the 2021 season. He plans to make $ 24 million in 2022 and 2023. This is the last two years of the $ 240 million 10-year contract signed with the Seattle Mariners before the 2014 season.
This is Kano’s second suspension for using performance-enhancing drugs. While he was a member of the Mariners, he was suspended for 80 games in 2018.
Kano was bought by the Mariners to Mets before the 2019 season in a deal that saw Mets send top prospects Jarred Kelenic and Justin Dunn to Seattle.
He entered the downseason in 2019, recording only .256 with 13 home runs and a slugging percentage of .428 with 390 at bats in 2019, but rebounded in 2020 when the pandemic was shortened and hit 10 home runs. And recorded .316 at .544. Slugging percentage of 171 at bats.
Kano started his career at the Yankees in 2005 and played for the Bronx until the 2013 season. He has made five All-Star appearances as a Yankee and won the World Series title in 2009. During my stay in Seattle, I made three more All-Star appearances.
Kano of Mets interrupted 162 games after a positive PED test
Source link Kano of Mets interrupted 162 games after a positive PED test